Business
Scientia Doses Ahead of Schedule in Phase I/II UTI Trial
Scientia Doses Ahead of Schedule in Phase I/II UTI Trial
About this update from Recce Pharmaceuticals Ltd.
[{"type":"text","content":"Recce Ltd has released a press release. View Attachment","length":235,"tagName":"div"}]